We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

149 hedge funds and large institutions have $2.48B invested in Ironwood Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 63 increasing their positions, 39 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 39

23% more call options, than puts

Call options by funds: $12.9M | Put options by funds: $10.4M

7.5% more ownership

Funds ownership: 131.45% → 138.95% (+7.5%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

11% less funds holding

Funds holding: 167 → 149 (-18)

11% less capital invested

Capital invested by funds: $2.78B → $2.48B (-$305M)

54% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 28

Holders
149
Holders Change
-18
Holders Change %
-10.78%
% of All Funds
3.71%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
13
Increased
63
Reduced
39
Closed
28
Calls
$12.9M
Puts
$10.4M
Net Calls
+$2.44M
Net Calls Change
+$1.38M

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$46.3M
2
UBS AM
UBS AM
Illinois
+$46.1M
3
EC
EcoR1 Capital
California
+$28M
4
BM
Bridger Management
New York
+$23.2M
5
Deutsche Bank
Deutsche Bank
Germany
+$15.9M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$15.9M
2
Renaissance Technologies
Renaissance Technologies
New York
-$11.9M
3
Goldman Sachs
Goldman Sachs
New York
-$10.2M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$8.63M
5
Invesco
Invesco
Georgia
-$6.01M
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
51
AllianceBernstein
Tennessee
$3.24M -$411K -29,850 -11%
Fisher Asset Management
52
Fisher Asset Management
Washington
$3.17M -$29.4K -2,139 -0.9%
RSCM
53
Rock Springs Capital Management
Maryland
$3.15M +$3.29M +238,800 New
EAM
54
Eventide Asset Management
Massachusetts
$3.03M – – –
HHC
55
Hutchin Hill Capital
New York
$2.92M +$2.22M +161,309 +270%
Goldman Sachs
56
Goldman Sachs
New York
$2.82M -$10.2M -739,837 -78%
Thrivent Financial for Lutherans
57
Thrivent Financial for Lutherans
Minnesota
$2.7M – – –
Wells Fargo
58
Wells Fargo
California
$2.62M +$1.01M +73,479 +59%
RhumbLine Advisers
59
RhumbLine Advisers
Massachusetts
$2.46M +$24.7K +1,793 +1%
BCB
60
Brian C. Broderick
$2.28M – – –
Russell Investments Group
61
Russell Investments Group
United Kingdom
$2.26M +$680K +49,439 +41%
Citigroup
62
Citigroup
New York
$2.11M -$141K -10,216 -6%
AA
63
ALPS Advisors
Colorado
$2.1M +$197K +14,340 +10%
Ohio Public Employees Retirement System (OPERS)
64
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.91M +$90.6K +6,582 +5%
CEP
65
Chicago Equity Partners
Illinois
$1.86M -$537K -39,038 -22%
Macquarie Group
66
Macquarie Group
Australia
$1.75M -$2.24M -162,959 -55%
WMSA
67
Weiss Multi-Strategy Advisers
New York
$1.74M – – –
PP
68
Paloma Partners
Connecticut
$1.69M +$905K +65,740 +105%
ERSOT
69
Employees Retirement System of Texas
Texas
$1.66M – – –
PIM
70
Platinum Investment Management
Australia
$1.65M – – –
Manulife (Manufacturers Life Insurance)
71
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.63M -$23.7K -1,720 -1%
Parallax Volatility Advisers
72
Parallax Volatility Advisers
California
$1.49M +$1.55M +112,494 New
CIA
73
Capital Impact Advisors
Massachusetts
$1.47M +$634K +46,056 +70%
MLICM
74
Metropolitan Life Insurance Company (MetLife)
New York
$1.44M – – –
AIG
75
American International Group
New York
$1.42M +$111K +8,060 +8%
1 2
3
4 5

IRWD Hedge Fund Activity: Q3 2017 in Review

149 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q3 2017, worth a combined $2.48B — down 11% from $2.78B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of IRWD and 13 opened new positions — a net loss of 15 holders — while 39 trimmed existing stakes and 63 added.

The largest buyer was BVF Inc, opening a new position worth an estimated $46.3M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $15.9M sold.

  • 149 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q3 2017, down from 167 in Q2 2017.
  • Funds reported $2.48B of Ironwood Pharmaceuticals stock for Q3 2017, down 11% quarter-over-quarter.
  • 13 funds opened new Ironwood Pharmaceuticals positions in Q3 2017 and 28 closed out, a net change of -15 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q3 2017 was BVF Inc, an estimated $46.3M added.
  • The largest Ironwood Pharmaceuticals seller in Q3 2017 was Point72 Asset Management, an estimated $15.9M sold.

Based on aggregated 13F filings for Q3 2017.